C29 suppressed the expression of COX-2 and iNOS and the activation of NF−κB in the hippocampus and ameliorated aging-dependent memory impairment by inhibiting the NF−κB signaling pathway (Jeong et al., 2015). Here, NFKB1 is linked to memory impairment.